The role of cell surfaces and cellular receptors in the mode of action of recombinant factor VIIa-Reference-Cited by-同舟云学术

The role of cell surfaces and cellular receptors in the mode of action of recombinant factor VIIa

Published:2015-07 Issue:4 Volume:29 Page:223-229
ISSN:0268-960X
Container-title:Blood Reviews
language:en
Short-container-title:Blood Reviews

Author:

Lisman Ton,de Groot Philip G.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference70 articles.

1. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors;Key;Thromb Haemost,1998

2. Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery;Shapiro;Thromb Haemost,1998

3. Off-label use of recombinant factor VIIa in U.S. hospitals: analysis of hospital records;Logan;Ann Intern Med,2011

4. Replacement therapy for bleeding episodes in factor VII deficiency. A prospective evaluation;Mariani;Thromb Haemost,2013

5. Congenital and acquired platelet disorders: current dilemmas and treatment strategies;White;Semin Hematol,2006

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Concizumab improves clot formation in hemophilia A under flow;Journal of Thrombosis and Haemostasis;2024-09

2. Coagulation protease–induced extracellular vesicles: their potential effects on coagulation and inflammation;Journal of Thrombosis and Haemostasis;2024-08

3. Critical Bleeding in Acquired Hemophilia A: Bypassing Agents or Recombinant Porcine Factor VIII?;Hämostaseologie;2020-09-11

4. Microfluidic hemophilia models using blood from healthy donors;Research and Practice in Thrombosis and Haemostasis;2019-12-02

5. Enhanced potency of recombinant factor VIIa with increased affinity to activated platelets;Journal of Thrombosis and Haemostasis;2019-10-14